|
|
||||||||||||||
|
|
|||||||||||||||
LESSON OF THE MONTH |
1 Department of Medical Genetics, University of Cambridge, UK
2 Department of Neurology, Addenbrookes Hospital, Cambridge, UK
Correspondence to:
Correspondence to:
Dr E Reid
Department of Medical Genetics, Box 134, Addenbrookes Hospital, Cambridge, CB2 2QQ, UK; ereid{at}hgmp.mrc.ac.uk
ABSTRACT
We present a family in which an initial clinical diagnosis of autosomal dominant pure hereditary spastic paraparesis (HSP) was made on the basis of a three generation pedigree in which both males and females presented with a spastic paraparesis. Subsequent biochemical and genetic analysis revealed that the family was in fact affected by the adrenomyeloneuropathy subtype of X-linked adrenoleukodystrophy. In the family described, both males and females were affected by a spastic paraparesis, and there was no male to male transmission, consistent with both autosomal dominant and X-linked inheritance. This report illustrates the importance of assaying very long chain fatty acids (VLCFAs) in any HSP family where there is no male to male transmission.
Keywords: X-linked adrenoleukodystrophy; hereditary spastic paraparesis
Abbreviations: ALD, adrenoleukodystrophy; AMN, adrenomyeloneuropathy; HSP, hereditary spastic paraplegia; MRI, magnetic resonance imaging; VLCFAs, very long chain fatty acids
This article has been cited by other articles:
![]() |
S H Wong, M Boggild, T P Enevoldson, and N A Fletcher Myelopathy but normal MRI: where next? Practical Neurology, April 1, 2008; 8(2): 90 - 102. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |